Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.69 |
| ▸ | PKM | P14618 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | ABL1 | P00519 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | IDE | P14735 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | CA12 | O43570 | 4/20 | 0.63 |
| ▸ | CA1 | P00915 | 4/20 | 0.63 |
| ▸ | CA2 | P00918 | 4/20 | 0.63 |
| ▸ | CA9 | Q16790 | 4/20 | 0.63 |
| ▸ | HLCS | P50747 | 3/20 | 0.57 |
| ▸ | F2 | P00734 | 1/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.57 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.57 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.57 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3306968 | 1.00 | TDP1 (0.69) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL23514610 | 1.00 | TDP1 (0.69) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL14255199 | 0.97 | TDP1 (0.71) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL9412852 | 0.93 | TDP1 (0.74) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL9441571 | 0.92 | TDP1 (0.71) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL12650837 | 0.92 | TDP1 (0.71) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL12578920 | 0.92 | TDP1 (0.71) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL20129535 | 0.91 | FOLH1 (0.67) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL18779801 | 0.90 | TDP1 (0.78) | TDP1PKMMEN1ABL1LMNA | |
| SCHEMBL12650835 | 0.90 | TDP1 (0.71) | TDP1PKMMEN1ABL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318696-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2012-11-27 | — | — | US | disclosed |
| US-8318696-B2 | Polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative | SANOFI (FR) | 2012-11-27 | — | — | US | disclosed |
| US-20120021933-A1 | SMALL MOLECULE PRINTING | PARK SEUNG BUM (US) | 2012-01-26 | — | — | US | disclosed |
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SANOFI-AVENTIS (FR) | 2011-06-16 | — | — | US | disclosed |
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SANOFI-AVENTIS (FR) | 2011-06-16 | — | — | US | disclosed |
| US-7932213-B2 | Solid phase synthesis with benzylidene linker attaching compound on glass slide; microarrays; drug screening | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144042-A1 | Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative | SERPINC1, SELP, FGB | TDP1 2935/4885PKM 4718/4885MEN1 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.